Researchers at Fox Chase Cancer Center have made a breakthrough in understanding how pancreatic cancer cells acquire nutrients and evade the immune system. The study, published in Nature Cancer, focused on the protein ANO6 and its role in the process of membrane exchange between cancer cells and surrounding fibroblasts. This exchange allows cancer cells to obtain cholesterol and other lipids, which is essential for their growth and survival. However, this process also weakens the immune cells that are meant to attack the cancer. By blocking the ANO6 protein, the researchers were able to slow down the growth of pancreatic tumors in mouse experiments. This finding suggests that targeting ANO6 could be a potential therapeutic strategy for pancreatic cancer. The study combined observations of human tissue with laboratory and animal experiments, providing a comprehensive understanding of the mechanisms involved. While the treatment findings are preclinical and have not been tested in patients, the study identifies a promising area of research that could lead to the development of new treatments for pancreatic cancer.